12 A recent meta-analysis of 26,894 obese participants without diabetes showed that semaglutide use increased the risk of gallbladder stones by 2.6 times, while this risk was not evident for tirzepatide
Science Progress meta-analysis (2026): Calculated a 3.4-fold increased risk of alopecia in GLP1 users versus placebo, with a confirmed dose dependency for semaglutide
To put that in perspective, the approved GLP-1 drugs achieved less weight loss in longer timeframes: for example, semaglutide (Wegovy) averages about 15% weight loss over ~16 months, and tirzepatide (Zepbound) achieved around 22.5% at 72 weeks in trials
Similarly, Volgers et al [74] studied high dose nebulized NAC in COPD patients and demonstrated that NAC exerts a strong bacteriostatic effect in patients with airway conditions
Rekha Lakshmanan 14:11 I think whats possibly missing from the conversation about adult immunizations is a reinforcement that adults need to be vaccinated as well
General inflammation and slow healing This is the broad bucket, and honestly it is the one most likely to lead to disappointment if expectations are not managed